Brooklyn Investment Group Acquires 71 Shares of Zoetis Inc. (NYSE:ZTS)

Brooklyn Investment Group lifted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 2.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,655 shares of the company’s stock after purchasing an additional 71 shares during the period. Brooklyn Investment Group’s holdings in Zoetis were worth $596,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in ZTS. Mercer Global Advisors Inc. ADV lifted its position in shares of Zoetis by 12.3% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 49,298 shares of the company’s stock valued at $8,530,000 after buying an additional 5,384 shares during the last quarter. Bristol Gate Capital Partners Inc. lifted its holdings in Zoetis by 14.4% during the second quarter. Bristol Gate Capital Partners Inc. now owns 540,791 shares of the company’s stock valued at $93,752,000 after purchasing an additional 68,189 shares during the last quarter. Intech Investment Management LLC boosted its position in Zoetis by 7,379.7% during the second quarter. Intech Investment Management LLC now owns 173,530 shares of the company’s stock worth $30,083,000 after purchasing an additional 171,210 shares during the period. Yost Capital Management LP purchased a new position in shares of Zoetis in the second quarter worth about $5,201,000. Finally, GM Advisory Group LLC bought a new stake in shares of Zoetis in the second quarter valued at approximately $243,000. Institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

ZTS has been the topic of a number of analyst reports. Leerink Partners began coverage on Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 price objective on the stock. Stifel Nicolaus lowered their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. JPMorgan Chase & Co. boosted their price objective on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. UBS Group assumed coverage on shares of Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target for the company. Finally, Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Zoetis presently has an average rating of “Buy” and a consensus price target of $211.89.

Zoetis Stock Performance

Shares of NYSE:ZTS opened at $166.01 on Friday. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. The company has a 50-day moving average price of $171.15 and a 200-day moving average price of $179.99. The company has a market cap of $74.90 billion, a price-to-earnings ratio of 31.20, a price-to-earnings-growth ratio of 2.51 and a beta of 0.89. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $200.53.

Zoetis (NYSE:ZTS) last announced its earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. The company had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.36 earnings per share. As a group, equities analysts anticipate that Zoetis Inc. will post 5.91 EPS for the current year.

Zoetis Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.20%. This is a boost from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date is Tuesday, January 21st. Zoetis’s dividend payout ratio is presently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.